Low-dose colchicine for statin intolerance pilot study
Part of Heart & circulation clinical trials.
This trial tests if a low dose of colchicine can help people who cannot take statins due to side effects. It aims to see if colchicine is safe and effective for lowering inflammation and improving cholesterol management.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had side effects from statins that went away when you stopped or lowered the dose
- You are 18 to 80 years old
- You have been on a stable cholesterol-lowering medicine (including statins or other drugs) for at least one month
- You do not have serious kidney or liver disease, severe heart failure, active cancer, or certain gut conditions like irritable bowel disease
- You are not currently taking colchicine or other anti-inflammatory drugs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if the anti-inflammatory drug colchicine can help people hospitalized with acute heart failure and a weak heart pump. It may benefit those with elevated inflammation markers.
This trial tests whether a low dose of the anti-inflammatory drug colchicine can help people who have recently had a heart attack or unstable angina. It aims to see if colchicine reduces the risk of future heart problems.
This trial tests if a low dose of colchicine, a medicine that reduces inflammation, can help improve blood vessel and bone health in people with moderate chronic kidney disease.
This trial tests whether low-dose colchicine can reduce “residual” risk—future heart and blood-vessel problems—in people with peripheral artery disease (PAD). It targets PAD symptoms and complications like poor blood flow in the legs, even after certain procedures.
This trial tests whether adding a targeted anti-inflammatory drug to standard care can prevent future heart attacks or strokes in people with high-risk chronic coronary artery disease. It is for people who have a moderate narrowing in a heart artery with a vulnerable plaque and signs of inflammation.
This trial tests whether colchicine (a medicine used for gout) can help prevent heart problems after a stent procedure (PCI). It's for people who are in the hospital getting a stent and follow standard heart care.
Hear when a new Statin Adverse Reaction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.